Carbonyl Reduction of Flubendazole in the Human Liver: Strict Stereospecificity, Sex Difference, Low Risk of Drug Interactions

Flubendazole (FLU), an anthelmintic drug of benzimidazole type, is now considered a promising anti-cancer agent due to its tubulin binding ability and low system toxicity. The present study was aimed at determining more information about FLU reduction in human liver, because this information has bee...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Front Pharmacol
Main Authors: Kubíček, Vladimír, Skálová, Lenka, Skarka, Adam, Králová, Věra, Holubová, Jana, Štěpánková, Jana, Šubrt, Zdeněk, Szotáková, Barbora
Format: Artigo
Jezik:Inglês
Izdano: Frontiers Media S.A. 2019
Teme:
Pharmacology
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC6546852/
https://ncbi.nlm.nih.gov/pubmed/31191322
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2019.00600
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki